Avricore Health’s HealthTab™ to Enable Real Time Reporting of COVID-19 Results in Pharmacy
September 09, 2020 08:30 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) ("Avricore" or the "Company") a leader in pharmacy-based point-of-care testing...
Avricore Health Corporate Update: Diversifies Revenues During COVID-19
June 29, 2020 09:44 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, June 29, 2020 (GLOBE NEWSWIRE) -- Avricore Health (TSXV: AVCR), like so many other business, has faced both challenges and opportunities over the past several weeks. ...
Point of Care (POC) Molecular Diagnostics Market Worth $2.39 Billion by 2027, Growing at a CAGR of 13.2% from 2019- Pre and Post COVID-19 Market Opportunity Analysis and Industry Forecasts by Meticulous Research®
June 22, 2020 10:36 ET
|
Meticulous Market Research Pvt. Ltd.
London, June 22, 2020 (GLOBE NEWSWIRE) -- POC molecular diagnostics include portable devices and assays & kits used to detect and diagnose diseases in human samples, such as throat swab, blood,...
Avricore’s HealthTab™ Coming to 11 New Community Pharmacy Locations
November 28, 2019 08:00 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Nov. 28, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce it will be placing HealthTab™...
Ontario Pharmacists and Avricore Health Partner to Expand HealthTab™ in Community Pharmacies and Enhance Patient Care
November 18, 2019 08:30 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) and the Ontario Pharmacists Association (OPA) are...
Point of Care Hemoglobin Analyzer Market To Reach USD 1,674.16 Million By 2026 | Reports And Data
November 06, 2019 10:26 ET
|
Reports and Data
New York, Nov. 06, 2019 (GLOBE NEWSWIRE) -- Growth in demand for anemia screening, demand from blood banks for disease screening, competitive prices, along with growing need for disease diagnosis...
Avricore Health Appoints CEO, President and Advisors
October 15, 2019 15:07 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) Board of Directors announces the appointment of...
OptimizeRx Signs Exclusive Agreement with NewCrop to Offer Digital Health Messages and Create a Health Tech Innovation Lab for Life Sciences
October 07, 2019 08:31 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., Oct. 07, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health solutions for payers, medtech companies, medical associations and the...
Avricore Health and Clinart MENA Announce Interim Agreement for HealthTab™ + RASTR Network Middle East Expansion
September 17, 2019 08:30 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) ("Avricore Health" or the "Company") is pleased to announce that it has signed a first...
Microfluidic Immunoassay Market Worth $2.01 Billion by 2025- Exclusive Report by Meticulous Research®
September 10, 2019 10:24 ET
|
Meticulous Market Research Pvt. Ltd.
London, Sept. 10, 2019 (GLOBE NEWSWIRE) -- According to a new market research report “Microfluidic Immunoassay Market by Product Type (Lab-on-chip, POC Analyzers, Reagents and Assay), Technology,...